openPR Logo
Press release

3rd edition of MEDLAB Asia Pacific unveils state of the art laboratory innovations

03-22-2016 01:19 PM CET | Health & Medicine

Press release from: Informa Life Sciences Exhibitions

3rd edition of MEDLAB Asia Pacific unveils state of the art

Singapore, Singapore: The 3rd MEDLAB Asia Pacific Exhibition and Conference, organised by Informa Life Sciences Exhibitions commenced today and will continue until March 24 2016. It is held at the Sands Expo and Convention Centre, Singapore. The conference programme will featured in total nine CME-accredited conference tracks, accredited by the Singapore Medical Council. The exhibition will feature some of the key industry leaders such as, BioMerieux, Bio-Rad, EUROIMMUN, Siemens, Abbott, Sysmex Mindray, and Snibe to name a few.

The exhibitors showcased some of their latest advanced products and services to an audience of laboratory specialists, and healthcare professionals. BioMerieux unveiled a series of new solutions providing efficient results, such as The FilmArray® Meningitis-Encephalitis Panel enabling rapid and accurate automated testing for the 14 most common pathogens responsible for community acquired meningitis or encephalitis including viruses, bacteria and yeast, which leads to better patient care. Sysmex showcased Sysmex’s Urinalysis modular system and Sysmex-Hyphen Bio-Med anticoagulant reagents. Sysmex Urinalysis modular concept provides a smart walkaway system to improve workflow and productivity. Sysmex-Hyphen Bio-Med anticoagulant reagent portfolio offers laboratories with a complete testing range for direct oral anticoagulants (DOACs) assays.

“MEDLAB Asia Pacific continues to be the optimum platform for the laboratory and healthcare industry in the Asia Pacific region to come together in order to exchange knowledge, and showcase scientific finding, instruments, products, and services. This exemplary event is only expected to grow exponentially from here,” highlighted Simon Page, Managing Director, Informa Life Sciences Exhibitions.

Bio-Rad Laboratories launched for the first time in South East Asia, their next generation of A1c testing equipment - D100. This technology, combined, improved HPLC accuracy and precision, high-throughput capacity, and simplified results review.

The Zika Virus has been one of the most talked about concerns in the healthcare industry, EUROIMMUN AG, a manufacturer of test systems and instruments for medical diagnostics, has developed the first commercial CE-IVD marked serological detection of Zika virus infections. The ELISA and indirect immunofluorescence tests from EUROIMMUN enable the determination of specific antibodies (IgM, IgG) against the virus is now available as CE-IVD marked. These tests are currently used in clinical study at the Fiocruz (Fundação Oswaldo Cruz), an institute linked to the Brazilian Ministry of Health.

“Our ELISAs are based on very specific, recombinant antigens which are produced in EUROIMMUN research laboratories. Positive results are a clear indicator of a Zika virus infection and the immunofluorescence mosaics help laboratory physicians to investigate patient samples for other viral fever diseases in parallel. This is important for differential diagnosis, since in Latin America there are also dengue and chikungunya viruses, which cause similar symptoms and are transmitted by the same species of mosquitoes as the Zika virus. We hope our test systems can help to clarify as soon as possible whether there is a link between the cases of microcephaly and Zika infections,” says Katja Steinhagen, head of the ELISA Infectious Serology department at EUROIMMUN AG.

Informa Life Sciences Exhibitions, in charge of the healthcare portfolio within Informa's Global Exhibitions division, organises 26 exhibitions yearly covering the Middle East, Africa, Asia, Europe and US market, connecting more than 150,000 healthcare professionals worldwide and offering a range of marketing solutions for companies involved with the healthcare sector. Over 100 congresses take place in parallel with the exhibitions.

Informa Life Sciences Exhibitions, Dubai, UAE 9428

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 3rd edition of MEDLAB Asia Pacific unveils state of the art laboratory innovations here

News-ID: 327750 • Views: 692

More Releases from Informa Life Sciences Exhibitions

Building Healthcare Exhibition delivers vital platform for decision makers in th …
Dubai, UAE: Building Healthcare Exhibition & Conferences, organised by Informa Life Sciences Exhibitions, will take place 30 May - June 1 2016, at the Dubai International Convention and Exhibition Centre. The exhibition will bring together more than 6,000 leading investors, healthcare CEOs, government representatives, IT decision makers, architects, and more, to discuss the future of healthcare and source the most cutting-edge technologies, products and services available to ensure the
Total Laboratory Automation Key Topic at MEDLAB Asia Pacific 2016
Singapore: Laboratories are under immense pressure to improve turnaround times, reduce human error rates, and improve efficiency while reducing costs. Those are the drivers for today’s automation of most of the clinical laboratories. Laboratory automation stands for the use of technology to minimalize or even eliminate manual handling of equipment and processes. In today’s fast moving healthcare industry, automation becomes crucial in laboratories for handling high volumes of samples at
Up to 30% of women in the GCC and South Asia suffer from infertility resulting f …
Dubai, UAE: There is a high incidence of polycystic ovarian syndrome (PCOS) in the Middle East/GCC region mainly due to hereditary and ethnic influences. Approximately up to 20-25% of women in the GCC of Middle Eastern and South Asian ethnicity suffer from PCOS. Experts believe that cases can reach 30% or even higher in the subfertility population in the region. The Obs Gyne Conference aims to tackle the different challenges,
Better management of insulin resistance needed for UAE women with Polycystic Ova …
Polycystic Ovary Syndrome (PCOS) is one of the most common female hormonal disturbances in the Middle East. The relationship between PCOS and insulin resistance is particularly important here in the UAE where 1 in 5 of the female population suffer from type 2 diabetes and other metabolic syndromes. Professor Samia Farghaly, Head of Academic Department, Primary Healthcare, Dubai Health Authority, Dubai, UAE, will be addressing the issue of ‘Investigation and Management

All 5 Releases